-
26/12/2018 12:48
0
leo115
N° messaggi: 2539 -
Iscritto da: 23/10/2014
Grafico Intraday: Johnson and Johnson | Grafico Storico: Johnson and Johnson | | |
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
|
1 di 4
-
26/12/2018 12:52
0
leo115
N° messaggi: 2539 -
Iscritto da: 23/10/2014
...
|
MODERATO
RAZIO
(Utente disabilitato)
N° messaggi: 430 -
Iscritto da: 27/3/2019
|
MODERATO
Betsabea
(Utente disabilitato)
N° messaggi: 2352 -
Iscritto da: 09/4/2020
|
4 di 4
-
24/4/2023 16:30
0
Gianni Barba
N° messaggi: 33168 -
Iscritto da: 26/4/2020
Johnson & Johnson sta preparando il roadshow per la potenziale quotazione del suo segmento di consumer health, che prenderà la denominazione di Kenvue. L’obiettivo dell’azienda è raccogliere almeno 3,5 miliardi di dollari, che porterebbe il valore dell’operazione a 40 miliardi. Dopo un roadhshow che potrebbe durare anche una settimana, il titolo debutterebbe alla Borsa di New York. J&J ha svelato il piano di separazione e quotazione della divisione consumer nel 2021. Il segmento produce farmaci da banco, cerotti, prodotti per la cura dei bambini e per la cura della pelle. Nel 2022 ha generato ricavi globali per 14,95 miliardi (il 15,7% del fatturato totale di J&J). Secondo il progetto, dopo l’ipo, J&J manterrà la maggioranza.
|